Skip to main content
Top
Published in: Pain and Therapy 2/2019

Open Access 01-12-2019 | Migraine | Original Research

Effect of Migraine Headache on Productivity of Patients According to Migraine Disability Assessment Score: A Cross-Sectional Study

Authors: Shafaq Jawed, Waqar Ali, Uzair Yaqoob, Shahnaz Shah, Syed Mohammad Mazhar Uddin, Aatera Haq

Published in: Pain and Therapy | Issue 2/2019

Login to get access

Abstract

Introduction

Migraine, a primary headache disorder, is usually recurrent with moderate to severe intensity. Migraine is the third most common cause of disability under the age of 50. There are various scoring systems for assessing this disability, one of which is MIDAS; the Migraine Disability Assessment Score. The objective of our study was to determine the extent of disability among migraine patients, patterns of prophylaxis, and their healthcare-seeking behaviors.

Methods

This survey was done in 50 migraine patients at Jinnah postgraduate medical Centre from April to May 2018. The questionnaire inquired about the demographic information, management of migraine, and effect of this condition on their sleep, and the last part had assessment to know about their functional disability.

Results

The majority of the patients were females with a mean age of 31 ± 10 years. Acetaminophen was the most common medication used during a migraine attack, followed by nonsteroidal anti-inflammatory drugs. Only 54% of subjects admitted using prophylaxis, out of which 94% had stopped taking it after some time, with the most common reason being their side effects. β-blockers were the most common prophylaxis used. Only 32% had a regular follow-up visit with their doctors. Patients were graded according to the MIDAS score as: little or no disability, 22%; mild disability, 14%; moderate disability, 24%; and severe disability, 40%.

Conclusions

The majority of migraine patients were found to have severe disability, which affected their daily work and social activities. Despite an increase in disability rate due to migraine, people do not seek regular medical care for this type of headache in Pakistan.
Literature
1.
go back to reference Aminoff RP, Simon DA, Greenberg MJ, editors. Clinical neurology. 7th ed. New York: Lange Medical Books/McGraw-Hill; 2009. p. 85–8. Aminoff RP, Simon DA, Greenberg MJ, editors. Clinical neurology. 7th ed. New York: Lange Medical Books/McGraw-Hill; 2009. p. 85–8.
2.
go back to reference World Health Organisation—Headache disorders Fact sheet No. 277. 2016. World Health Organisation—Headache disorders Fact sheet No. 277. 2016.
4.
go back to reference Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the migraine disability assessment (MIDAS) questionnaire. Headache J Head Face Pain. 2001;41(9):854–61.CrossRef Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the migraine disability assessment (MIDAS) questionnaire. Headache J Head Face Pain. 2001;41(9):854–61.CrossRef
5.
go back to reference Raggi A, Covelli V, Leonardi M, Grazzi L, Curone M, D’Amico D. Difficulties in work-related activities among migraineurs are scarcely collected: results from a literature review. Neurol Sci. 2014;35(1):23–6.CrossRef Raggi A, Covelli V, Leonardi M, Grazzi L, Curone M, D’Amico D. Difficulties in work-related activities among migraineurs are scarcely collected: results from a literature review. Neurol Sci. 2014;35(1):23–6.CrossRef
8.
go back to reference Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF). J Headache Pain. 2005;6(6):429.CrossRef Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF). J Headache Pain. 2005;6(6):429.CrossRef
9.
go back to reference Yalinay Dikmen P, Yavuz BG, Aydinlar EI. The relationships between migraine, depression, anxiety, stress, and sleep disturbances. Acta Neurol Belg. 2015;115(2):117–22.CrossRef Yalinay Dikmen P, Yavuz BG, Aydinlar EI. The relationships between migraine, depression, anxiety, stress, and sleep disturbances. Acta Neurol Belg. 2015;115(2):117–22.CrossRef
10.
go back to reference Stavem K, Kristiansen HA, Kristoffersen ES, Kværner KJ, Russell MB. Association of excessive daytime sleepiness with migraine and headache frequency in the general population. J Headache Pain. 2017;18(1):35.CrossRef Stavem K, Kristiansen HA, Kristoffersen ES, Kværner KJ, Russell MB. Association of excessive daytime sleepiness with migraine and headache frequency in the general population. J Headache Pain. 2017;18(1):35.CrossRef
11.
go back to reference Bendtsen L, Munksgaard SB, Tassorelli C, Nappi G, Katsarava Z, Lainez M, et al. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia. 2014;34(6):426–33.CrossRef Bendtsen L, Munksgaard SB, Tassorelli C, Nappi G, Katsarava Z, Lainez M, et al. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia. 2014;34(6):426–33.CrossRef
12.
go back to reference Murtaza M, Kisat M, Daniel H, Sonawalla AB. Classification and clinical features of headache disorders in Pakistan: a retrospective review of clinical data. PLoS One. 2009;4(6):e5827.CrossRef Murtaza M, Kisat M, Daniel H, Sonawalla AB. Classification and clinical features of headache disorders in Pakistan: a retrospective review of clinical data. PLoS One. 2009;4(6):e5827.CrossRef
13.
go back to reference Noor T, Sajjad A, Asma A. Frequency, character and predisposing factor of headache among students of medical college of Karachi. J Pak Med Assoc. 2016;66(2):159–64.PubMed Noor T, Sajjad A, Asma A. Frequency, character and predisposing factor of headache among students of medical college of Karachi. J Pak Med Assoc. 2016;66(2):159–64.PubMed
14.
go back to reference Zahid M, Sthanadar AA, Kaleem M, Latif M, Sthanadar IA, Ali PA, Ismail M, Imtiaz N, Shah M. Prevalence and perceptions about migraine among students and patients in Khyber Pakhtunkhwa Province, Pakistan. Adv Biosci Biotechnol. 2014;5(6):508–16.CrossRef Zahid M, Sthanadar AA, Kaleem M, Latif M, Sthanadar IA, Ali PA, Ismail M, Imtiaz N, Shah M. Prevalence and perceptions about migraine among students and patients in Khyber Pakhtunkhwa Province, Pakistan. Adv Biosci Biotechnol. 2014;5(6):508–16.CrossRef
15.
go back to reference Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20–8.CrossRef Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20–8.CrossRef
16.
go back to reference García ML, Baos V, Láinez M, Pascual J, López-Gil A. Responsiveness of migraine-ACT and MIDAS questionnaires for assessing migraine therapy. Headache J Head Face Pain. 2008;48(9):1349–55.CrossRef García ML, Baos V, Láinez M, Pascual J, López-Gil A. Responsiveness of migraine-ACT and MIDAS questionnaires for assessing migraine therapy. Headache J Head Face Pain. 2008;48(9):1349–55.CrossRef
17.
go back to reference Ghorbani A, Chitsaz A. Comparison of validity and reliability of the Migraine Disability Assessment (MIDAS) versus headache impact test (HIT) in an Iranian population. Iran J Neurol. 2011;10(3–4):39–42.PubMedPubMedCentral Ghorbani A, Chitsaz A. Comparison of validity and reliability of the Migraine Disability Assessment (MIDAS) versus headache impact test (HIT) in an Iranian population. Iran J Neurol. 2011;10(3–4):39–42.PubMedPubMedCentral
18.
go back to reference Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edn. Cephalalgia. 2018;38(1):1–211. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edn. Cephalalgia. 2018;38(1):1–211.
19.
go back to reference Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(10):1456–70.CrossRef Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(10):1456–70.CrossRef
20.
go back to reference D’Amico D, Grazzi L, Curone M, Di Fiore P, Proietti Cecchini A, Leonardi M, et al. Difficulties in work activities and the pervasive effect over disability in patients with episodic and chronic migraine. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2015;36(Suppl 1):9–11. D’Amico D, Grazzi L, Curone M, Di Fiore P, Proietti Cecchini A, Leonardi M, et al. Difficulties in work activities and the pervasive effect over disability in patients with episodic and chronic migraine. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2015;36(Suppl 1):9–11.
21.
go back to reference Park JW, Shin HE, Kim JS, Lee KS. Assessing migraine disability by diary-based measurement: relationship to the characteristics of individual headache attacks. Eur J Neurol. 2008;15(8):817–21.CrossRef Park JW, Shin HE, Kim JS, Lee KS. Assessing migraine disability by diary-based measurement: relationship to the characteristics of individual headache attacks. Eur J Neurol. 2008;15(8):817–21.CrossRef
23.
go back to reference Blumenfeld AM, Bloudek LM, Becker WJ, Buse DC, Varon SF, Maglinte GA, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II). Headache. 2013;53(4):644–55.CrossRef Blumenfeld AM, Bloudek LM, Becker WJ, Buse DC, Varon SF, Maglinte GA, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II). Headache. 2013;53(4):644–55.CrossRef
25.
go back to reference Usai S, Grazzi L, Andrasik F, D’Amico D, Rigamonti A, Bussone G. Chronic migraine with medication overuse: treatment outcome and disability at 3 years follow-up. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2004;25(Suppl 3):S272–3. Usai S, Grazzi L, Andrasik F, D’Amico D, Rigamonti A, Bussone G. Chronic migraine with medication overuse: treatment outcome and disability at 3 years follow-up. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2004;25(Suppl 3):S272–3.
26.
go back to reference Holland S, Fanning KM, Serrano D, Buse DC, Reed ML, Lipton RB. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. J Neurol Sci. 2013;326(1–2):10–7.CrossRef Holland S, Fanning KM, Serrano D, Buse DC, Reed ML, Lipton RB. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. J Neurol Sci. 2013;326(1–2):10–7.CrossRef
Metadata
Title
Effect of Migraine Headache on Productivity of Patients According to Migraine Disability Assessment Score: A Cross-Sectional Study
Authors
Shafaq Jawed
Waqar Ali
Uzair Yaqoob
Shahnaz Shah
Syed Mohammad Mazhar Uddin
Aatera Haq
Publication date
01-12-2019
Publisher
Springer Healthcare
Keywords
Migraine
Headache
Published in
Pain and Therapy / Issue 2/2019
Print ISSN: 2193-8237
Electronic ISSN: 2193-651X
DOI
https://doi.org/10.1007/s40122-019-0130-4

Other articles of this Issue 2/2019

Pain and Therapy 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.